Wuxi Pushing Ahead with $3bn Go-Private Deal
This article was originally published in Scrip
Executive Summary
Despite the market turmoil on China’s stock exchanges since June, US-listed Chinese healthcare-related companies have not stepped back from privatization plans and the consideration of floating again on Chinese bourses, given the encouraging policies and promising development environment in the country.